• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

U.S. FDA

FDA
Favicon Fierce Pharma

Biopharma rallies behind Pazdur to lead FDA. But is he willing?

Pazdur last month suggested that another administration would need to occupy the White House before he might consider returning to the FDA.
Fraiser Kansteiner May 14, 2026 11:05am
Martin Makary FDA Senate HELP confirmation
Favicon Fierce Pharma

FDA's embattled Marty Makary steps down as commissioner

May 12, 2026 2:30pm
stop train halt end road block railway

FDA demands ph. 3 trial of uniQure's Huntington's gene therapy

Mar 2, 2026 10:45am
Vinay Prasad

FDA to ‘carefully shepherd’ CAR-T for autoimmune disease: Prasad

Feb 3, 2026 11:40am
2026 year ahead look ahead preview forecast new year
Favicon Fierce Pharma

3 biopharma CEOs explain why they are 'authentically optimistic'

Jan 6, 2026 11:54am
Makary

FDA unveils new pathway to speed custom gene editing therapies

Nov 12, 2025 5:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings